Koneksa CEO Joins Industry Panel on Artificial Intelligence

“Biopharma needs to radically improve the speed with which it innovates and to deliver differentiated medicines that provide more value, backed by real world evidence. Is artificial intelligence just the latest buzzword, or is it a real panacea to the industry’s ills?”

This is the description for the Digital Health panel that Koneksa CEO Chris Benko is speaking at today at the 2018 BIO International Convention.

The panel is titled “Artificial intelligence and machine learning: just buzzwords or breakthroughs that will truly accelerate biotech innovation?” It will provide a look at how the industry is currently using technology and machine learning to accelerate innovation and deliver it to patients.

Chris joins: